CN1424870A - 用挑选的供体细胞实施核移植 - Google Patents

用挑选的供体细胞实施核移植 Download PDF

Info

Publication number
CN1424870A
CN1424870A CN00813845A CN00813845A CN1424870A CN 1424870 A CN1424870 A CN 1424870A CN 00813845 A CN00813845 A CN 00813845A CN 00813845 A CN00813845 A CN 00813845A CN 1424870 A CN1424870 A CN 1424870A
Authority
CN
China
Prior art keywords
cell
embryo
donorcells
animal
cloning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00813845A
Other languages
English (en)
Chinese (zh)
Inventor
戴维·韦尔斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGRES Ltd
Original Assignee
AGRES Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AGRES Ltd filed Critical AGRES Ltd
Publication of CN1424870A publication Critical patent/CN1424870A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/13Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323Adult fibroblasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/99Coculture with; Conditioned medium produced by genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00Cells related to new breeds of animals
    • C12N2517/10Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
CN00813845A 1999-09-14 2000-09-14 用挑选的供体细胞实施核移植 Pending CN1424870A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ337792 1999-09-14
NZ337792A NZ337792A (en) 1999-09-14 1999-09-14 Nuclear transfer and use in cloning

Publications (1)

Publication Number Publication Date
CN1424870A true CN1424870A (zh) 2003-06-18

Family

ID=19927507

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00813845A Pending CN1424870A (zh) 1999-09-14 2000-09-14 用挑选的供体细胞实施核移植

Country Status (8)

Country Link
JP (1) JP2004500038A (fr)
CN (1) CN1424870A (fr)
AR (1) AR032284A1 (fr)
AU (1) AU784371B2 (fr)
DE (1) DE10084987T1 (fr)
GB (1) GB2369828B (fr)
NZ (1) NZ337792A (fr)
WO (1) WO2001019182A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122177B2 (en) 2000-01-20 2006-10-17 Diabcell Pty Ltd. Preparation and xenotransplantation of porcine islets
JP2006508676A (ja) * 2002-12-10 2006-03-16 ジーティーシー バイオセラピューティックス インコーポレイテッド 追加の核移植のための細胞ドナーとして体細胞核移植胚を利用する方法および系
JP2006081542A (ja) * 2004-08-18 2006-03-30 Institute Of Physical & Chemical Research クローン哺乳動物の作成方法
JP2010075099A (ja) * 2008-09-26 2010-04-08 Japan Science & Technology Agency 哺乳動物核移植胚のスクリーニング方法、非ヒト哺乳動物核移植胚、クローン非ヒト哺乳動物、及びスクリーニングキット
EP3188763B1 (fr) * 2014-09-02 2020-05-13 The Regents of The University of California Procédés et compositions pour assurer la modification de l'adn cible arn dépendante
CN105483216B (zh) * 2015-11-30 2019-01-15 四川农业大学 一种家兔cetp基因检测肉质育种的方法
CN108624621B (zh) * 2018-01-17 2019-04-12 中国科学院上海生命科学研究院 非人灵长类的体细胞克隆动物的制备方法
JP2023516484A (ja) 2020-03-11 2023-04-19 ビット バイオ リミテッド 肝細胞作製方法
CN111793671A (zh) * 2020-07-22 2020-10-20 中国农业大学 一种优化的适用于绵羊染色体二元流式分选的染色体悬液制备方法
CN112715479A (zh) * 2021-01-06 2021-04-30 吉沙阿牛 一种山羊生态循环养殖方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1067834A4 (fr) * 1998-03-16 2002-01-23 Garelag Pty Ltd Transfert de noyau de cellules porcines

Also Published As

Publication number Publication date
JP2004500038A (ja) 2004-01-08
NZ337792A (en) 2002-03-28
WO2001019182A1 (fr) 2001-03-22
GB2369828A (en) 2002-06-12
DE10084987T1 (de) 2003-04-17
AU7462400A (en) 2001-04-17
AU784371B2 (en) 2006-03-23
GB0205915D0 (en) 2002-04-24
GB2369828B (en) 2004-12-01
AR032284A1 (es) 2003-11-05

Similar Documents

Publication Publication Date Title
CN1210066C (zh) 用来自分化细胞的供体核克隆猪的方法
CN1248288B (zh) 用分化胎儿和成年供体细胞进行的核转移
CN100335625C (zh) 来自有蹄动物胚胎的培养内细胞团细胞系
CN1200107C (zh) 以成年体细胞胞核重建的去核卵母细胞足月发育成动物
CN1230989A (zh) 通过种间核移植制备胚胎细胞或干细胞样细胞系
CN1265599A (zh) 使用来自无血清饥饿的分化细胞的供体细胞核进行克隆
CN1391605A (zh) 多能细胞和细胞系的单雌生殖或单雄生殖产生,及其产生分化细胞和组织的用途
CN1212009A (zh) 有蹄动物胚胎干样细胞、制法及用该细胞产生转基因的有蹄动物的方法
CN107937445A (zh) 利用体细胞克隆技术制备基因敲除犬的方法
CN1424870A (zh) 用挑选的供体细胞实施核移植
CN1377424A (zh) 由衰老体细胞克隆的动物中的端粒恢复和细胞寿命延长
Park et al. Assisted reproductive techniques and genetic manipulation in the common marmoset
CN1280412C (zh) 产生克隆胚胎和其子代的方法以及由所述方法生产的细胞
CN1582332A (zh) 转染gfp的克隆猪、敲除gt的克隆猪及其生产方法
CN1425064A (zh) 通过交叉物种核移植制备的胚胎或干样细胞
EP1779724A1 (fr) Construction de chimere a l'aide de cellules es
CN1299408A (zh) 通过异种间的核移植产生的胚细胞或干细胞样细胞系
CN1293188C (zh) 一种将长期培养的可包括人工诱导基因改变的雌或雄体细胞的细胞核转移到去核受体细胞中实现靶向基因改变的克隆动物的方法
CN1298841C (zh) 重建胚胎中核转移后融合和活化的方法和系统
CN1399513A (zh) 用于核移植的供体细胞的制备和选择
CN1377225A (zh) 使用来自分化细胞的供体细胞或细胞核克隆猪以及多能猪的生成
CN1447854A (zh) 来自猿猴的胚胎干细胞
CN1284851C (zh) 体细胞起源的胚胎干细胞及其分化细胞
KR20070101266A (ko) 동물 체세포 핵 이식과 연관된 유사분열 방추 결함의 교정및 착상 전 배아 발달율의 최적화 방법
KR20060057528A (ko) 동물에서 체세포 핵 전이와 연관된 유사분열 방추 결함을교정하는 방법

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication